Key Events This Week
15 Sep: Stock plunges 6.68% following downgrade to Hold
16 Sep: Technical momentum shifts amid market volatility
17 Sep: Modest gains of 0.45% as technical indicators show mixed signals
18 Sep: Strong rebound with 5.87% gain, closing near weekly highs

Caplin Point Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals
2026-09-16 08:56:46Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 15 Sep 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and consistent returns, evolving technical indicators and valuation concerns have tempered the outlook, prompting a more cautious stance among investors.
Read full news article
Caplin Point Laboratories Ltd: Technical Momentum Shifts Amid Market Volatility
2026-09-16 08:05:47Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a sharp 6.68% decline in the latest trading session, the stock’s year-to-date return remains robust at 39.63%, outperforming the Sensex by a wide margin.
Read full news article
Caplin Point Laboratories Ltd is Rated Buy
2026-09-14 10:10:32Caplin Point Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 02 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article









